tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ResMed reports Q1 EPS $2.55, consensus $2.50
PremiumThe FlyResMed reports Q1 EPS $2.55, consensus $2.50
2d ago
ResMed price target raised to $304 from $298 at Morgan Stanley
Premium
The Fly
ResMed price target raised to $304 from $298 at Morgan Stanley
11d ago
ResMed initiated with an Equal Weight at Wells Fargo
Premium
The Fly
ResMed initiated with an Equal Weight at Wells Fargo
19d ago
Resmed Inc Files Definitive Proxy Statement with SEC
PremiumCompany AnnouncementsResmed Inc Files Definitive Proxy Statement with SEC
30d ago
Resmed Inc Officer Plans Sale of Common Stock Under Rule 144
Premium
Company Announcements
Resmed Inc Officer Plans Sale of Common Stock Under Rule 144
1M ago
Resmed’s Strategic Positioning and Growth Prospects: A Buy Recommendation by Laura Sutcliffe
Premium
Ratings
Resmed’s Strategic Positioning and Growth Prospects: A Buy Recommendation by Laura Sutcliffe
1M ago
Resmed Inc Reports Decrease in CDIs for August 2025
PremiumCompany AnnouncementsResmed Inc Reports Decrease in CDIs for August 2025
2M ago
ResMed launches Sleep Institute
Premium
The Fly
ResMed launches Sleep Institute
2M ago
ResMed Inc Announces Proposed Sale of 3,000 Common Shares
Premium
Company Announcements
ResMed Inc Announces Proposed Sale of 3,000 Common Shares
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100